Aflac(AFL) - 2025 Q4 - Annual Report

Insurance Products and Market Position - Aflac Japan is the largest insurer in Japan for cancer and medical insurance products, significantly contributing to the Parent Company's consolidated earnings[29] - Aflac Japan launched a new cancer insurance product, Miraito, in March 2025, allowing customers to choose necessary coverage[31] - Aflac Japan's medical insurance product, Anshin Palette, was launched in December 2025, offering flexible coverage options[32] - By the end of 2025, Aflac Japan had approximately 6,300 sales agencies and around 112,000 licensed sales associates[38] - Aflac Japan has agreements with about 90% of banks in Japan to sell its insurance products[42] - Aflac U.S. had an average of approximately 5,300 agents actively producing business in 2025[59] - Aflac U.S. experiences higher new annualized premium sales in the fourth quarter, typically generating over one-third of total sales during this period[56] - Aflac U.S. competes in the supplemental insurance market against various carriers, focusing on product design, pricing, and policyholder service[60] Financial Performance and Risks - Aflac Japan's adjusted revenues accounted for 53% of the Company's total adjusted revenues in 2025, down from 55% in 2024 and 60% in 2023[114] - The percentage of the Company's total assets attributable to Aflac Japan was 76% at December 31, 2025, compared to 77% at December 31, 2024[114] - The Company is exposed to significant interest rate risk, which may adversely affect its results of operations, financial condition, and liquidity[108] - Low levels of interest rates in Japan and the U.S. have reduced the level of investment income earned by the Company[109] - A sustained decline in interest rates could hinder the Company's ability to earn the returns assumed in the pricing and reserving for its insurance products[110] - Rising interest rates could improve the Company's ability to earn higher rates of return on future investments, but may also negatively impact the fair values of fixed maturity investments[111] - The Company has reduced the proportion of U.S. dollar-denominated investments that are subject to a currency hedge, increasing earnings volatility[120] - Aflac Japan's concentration in Japanese government bonds exposes the Company to credit deterioration and potential downgrades[115] - The Company faces risks related to credit losses on investments, which are based on significant valuation judgments and could materially impact financial results[135] - Changes in interest rates, credit-related losses, or foreign exchange rates could trigger impairments that negatively impact Aflac Japan's earnings and capital deployment[139] Employee and Workforce Management - As of December 31, 2025, Aflac Japan employed 6,804 full-time employees, while Aflac U.S. had 5,117, totaling 12,716 employees[84] - Aflac Japan's employee health management initiatives earned it certification as one of the top 500 Leading Companies in Health and Productivity Management for the eighth consecutive year[89] - In 2025, women accounted for 55% of Aflac Japan's workforce and 34% of leadership roles, while 65% of Aflac U.S. employees were women, with women holding 51% of leadership roles[91] - Aflac Heartful Services, a subsidiary of Aflac Japan, employed 158 individuals, 124 of whom have disabilities, promoting a barrier-free work environment[92] - Aflac U.S. conducts employee engagement surveys every two years to capture feedback on company culture and overall satisfaction[93] - Aflac Japan launched the Aflac Leadership Academy in 2024 to develop next-generation management skills[86] - The company actively partners with colleges and universities to attract exceptional talent, providing internships and educational resources[87] - Aflac Japan's human capital management system allows employees to access job descriptions and necessary skills for career development[86] - The company has implemented health and wellness programs to encourage healthy lifestyles among employees in the U.S.[90] Regulatory and Compliance Issues - The Company must comply with various privacy and security regulations, and noncompliance could lead to significant fines and reputational damage[173] - Aflac Japan is subject to strict regulations regarding personal data leaks, which could result in mandatory reporting and reputational risks[174] - The effectiveness of the Company's risk management framework is uncertain, and failures could lead to unexpected losses[163][165] - The Company’s ability to pay dividends may be constrained by its subsidiaries' financial strength ratings and regulatory limitations[161][162] - The Company is subject to extensive regulation and changes in legislation that can impact profitability and growth, with potential adverse effects on financial condition and results of operations[176] - Compliance with applicable laws and regulations is time-consuming and may materially increase the Company's compliance expenses, adversely affecting financial condition[178] Technology and Cybersecurity - The Company is investing in technology and digital capabilities to enhance customer experience and improve operational efficiencies[154] - The development of new technology, including artificial intelligence (AI), poses increased risks of business interruptions and cybersecurity breaches[154] - The Company has experienced cyber incidents, including a significant data exfiltration event in June 2025, which could adversely affect its financial condition[156] - The Company relies on third-party vendors for business support, exposing it to operational risks that could disrupt services and impact revenues[168] Market Competition and Strategic Challenges - The Company operates in a competitive environment, facing pressures from customer demands and potential competition from new entrants, which could affect market share and profitability[179] - Future success depends on the ability to keep pace with rapid technological changes and effectively implement new technology-driven products and services[180] - Catastrophic events, including pandemics and natural disasters, could cause substantial volatility in financial results and materially reduce profitability[181] - The Company's reputation is critical to maintaining policyholder trust, and negative perceptions could adversely affect sales and financial condition[184] - The loss of key management personnel could significantly undermine the Company's management expertise and adversely affect business operations[185] - Changes in accounting standards could have a material adverse effect on the Company's financial statements and results of operations[186] - Allegations of agent misclassification could result in significant costs and adversely affect the Company's business and financial condition[188]